Clin2
NCT06065267Possibly a fitNot yet recruiting

Levofloxacin treatment for H. pylori infection

Helicobacter Pylori Infection

Treatments studied

Part of Digestive system, Infections clinical trials.

This trial compares two ways of taking the antibiotic levofloxacin to treat H. pylori, a bacteria that can cause stomach ulcers. If you have H. pylori and haven't been treated for it before, this study may help find the best way to get rid of the infection.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
150 people
Ages
18 years to 80 years
Study type
Interventional

Who can take part

  • You are over 18 years old.
  • You have H. pylori infection confirmed by a test.
  • You have never been treated for H. pylori before.
  • You have not taken antibiotics or stomach acid reducers recently.
  • You have not had stomach surgery or stomach cancer.
  • You are not pregnant or breastfeeding.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07624422Not yet recruiting· Phase 4
Helicobacter pylori infection treatment study

This study tests a new antibiotic combination to treat stomach infections caused by H. pylori bacteria. It may help clear the infection and reduce stomach problems.

Damascus
NCT07021729Not yet recruiting· Phase 4
Comparing two treatments for H. pylori infection

This trial compares two antibiotic combinations to treat H. pylori, a common stomach infection. It may help you get rid of the infection more effectively.

NCT06200779Not yet recruiting· Phase 4
Personalized versus standard treatment for H. pylori infection

This study is testing whether giving H. pylori treatment based on the specific bacteria found in your stomach works better than the standard one-size-fits-all approach. If you are already getting an endoscopy with a biopsy, this trial could help find the most effective medication for your infection.

Porto, Porto District
NCT06929962Recruiting· Phase 4
VA dual sequential therapy for H. pylori gastritis

This trial tests a new two-step antibiotic treatment for adults with chronic gastritis caused by H. pylori bacteria. If you have not been treated for H. pylori before and are between 18 and 70, you may be able to join.

Nanjing, Jiangsu
NCT07439445Recruiting
Simplified treatment for H. pylori guided by a stool test

This trial tests a simpler two-drug treatment for H. pylori infection, chosen based on a stool test that checks if the bacteria are resistant to clarithromycin. It may help people who have not been treated before avoid unnecessary antibiotics.

Beijing, Beijing Municipality
NCT07537634Recruiting· Phase 4
New stomach acid medicine versus standard treatment for H. pylori infection

This trial compares two different antibiotic combinations to treat H. pylori, a common stomach bacteria that causes indigestion and ulcers. One uses a newer acid-blocking medicine (vonoprazan) and the other uses a standard one (esomeprazole), both paired with antibiotics.

Dhaka

Hear when a new Helicobacter Pylori Infection trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.